August 29, 2018

Media

Media & events

news

Lyndra Therapeutics Takes on Opioid Use Disorder with Long-Acting Oral Dosage Form

April 9, 2019
Lyndra Therapeutics Takes on Opioid Use Disorder with Long-Acting Oral Dosage Form NIH Grant Fuels Development of Once-Weekly Oral Buprenorphine...
Read More

publications

  • Development of an Oral Once-Weekly Drug Delivery System for HIV Antiretroviral Therapy
    Development of an Oral Once-Weekly Drug Delivery System for HIV Antiretroviral Therapy
nature-communications
nature-communications
Development of an Oral Once-Weekly Drug Delivery System for HIV Antiretroviral Therapy

Article OPEN Published: 

Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy

Ameya R. Kirtane, Omar Abouzid, Daniel Minahan, Taylor Bensel, Alison L. Hill, Christian Selinger, Anna Bershteyn, Morgan Craig, Shirley S. Mo, Hormoz Mazdiyasni, Cody Cleveland, Jaimie Rogner, Young-Ah Lucy Lee, Lucas Booth, Farhad Javid, Sarah J. Wu, Tyler Grant, Andrew M. Bellinger, Boris Nikolic, Alison Hayward, Lowell Wood, Philip A. Eckhoff, Martin A. Nowak, Robert Langer & Giovanni Traverso

Nature Communications volume 9, Article number: 2 (2018Download Citation

URL : View Project

events

Lyndra Presents @ BIO International

Join us on Thursday, June 5th, at 5pm when Andrew Bellinger, our CSO, presents our 2019 Company Update at BIO International, Philadelphia Convention Center, Theater 4

2019 BIO International

awards

2019 Xconomy Awards Finalist in Startup Category

We are honored to be named a finalist for the Awards in the category for our work making daily pills a thing of the past.

#XconomyAwards